SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

NASA JPLs selection of Intuitive Machines for the FALCON-RADAR spacecraft platform is drawing attention alongside the companys other NASA contract wins. Traders are encouraged by the expanding work, but some question its near-term financial impact because the contract value has not been disclosed, amid continued concern over the stocks steep decline and volatility.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys multiyear engine, technology-licensing and engineering deal with AST SpaceMobile for its planned heavy-lift rocket is driving attention, with traders viewing it as validation of Fireflys propulsion business and a boost to its backlog. The community reaction is broadly bullish after the sharp rally and break above a key round-number level, though some traders question the deals payment terms and the value of AST shares included in the consideration.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs stronger-than-expected quarterly results and higher full-year revenue outlook are driving attention, alongside renewed strength across quantum-computing stocks. Traders are celebrating the growth and backlog, while others remain wary of cash burn, dilution, and whether reported growth will translate into sustained commercial demand.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings Q3 miss and sharply reduced FY26 outlook have driven a steep selloff, with traders focusing on the heavy cost of expanding its Predictions business and whether that spending can pay off. Bears question management, profitability, and competitive pressure from prediction-market rivals, while some bulls argue the core sportsbook is still growing and see the drop as a buying opportunity.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Strong Q3 results, raised revenue guidance and a higher long-term outlook are driving Xeris Biopharmas sharp move, with traders pointing to Recorlevs growth as a key factor. The community is largely celebrating a potential re-rating, while takeover talk remains speculation rather than a confirmed catalyst.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins strong quarterly results, higher outlook and expanded share-repurchase authorization sparked a sharp rally, with traders crediting continued gains from its AI-powered advertising model. Bulls see a potential turnaround and point to the stocks resilience amid a broader tech selloff, while skeptics warn the move may be overextended and vulnerable to profit-taking.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broad AI and semiconductor selling has driven a sharp slide in AVGO, with traders worried that data-center spending could slow and that the companys custom-chip business depends heavily on a few large customers and their financing. The community is split between frustrated bears pointing to persistent underperformance and dip buyers arguing that AI demand remains intact and the selloff is overdone.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklos sharp rebound is being linked to its Q3 update and a manufacturing agreement reserving future reactor-component capacity. Bulls view the deal as progress toward deployment, while skeptics point to the companys pre-revenue status, long commercialization timeline, and dilution concerns.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axons post-earnings selloff follows a quarterly miss and a cut to its full-year outlook, with federal procurement delays cited as a headwind. Traders are split between viewing the steep drop as an oversold buying opportunity and seeing it as a repricing of a richly valued stock.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Discussion centers on POETs reported appearance in Foxconns photonics ecosystem at Tech Day, which traders see as validation of its optical-engine collaboration and potential AI data-center demand. Bulls speculate this could lead to orders, while skeptics stress that a demo is not proof of production shipments and want concrete commercialization updates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX)

Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of...

Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) Wolf Haldenstein Adler...

Rosen Law Firm Encourages Curanex Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation CURX

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) resulting...

What's Behind Curanex Pharmaceuticals (CURX) 56% Surge After Hours

Curanex Pharmaceuticals shares surged in after-hours trading after the company completed a GMP-compliant batch supporting its planned IND submission for ulcerative colitis. read more...

Curanex Pharmaceuticals, Inc. engages in the pharmaceutical business. It focuses on developing and commercializing botanical treatments for inflammatory diseases. The company was founded by Ying Jing and Chang Liu in 1996 and is headquartered in Jericho, NY.

Curanex Pharmaceuticals Inc.

Bullish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

Curanex Pharmaceuticals Inc

$CURX If these clowns were smart they wouldn't try to get FDA approved as a drug but as a supplement, much easier and quicker and they could sell 100x more product.

Slide First

$CURX currently faces two securities class actions filed in New York courts, with response deadlines extended to Nov 15 and Dec 11.

Feed

News

Sentiment

Fundamentals

Info

CURX Curanex Pharmaceuticals Inc

Fundamentals

Latest CURX News